Structure of Tucatinib
CAS No.: 937263-43-9
*Storage:
*Shipping:
Irbinitinib is a potent and selectiveHER2 inhibitor with IC50 of 8 nM, equipotent against truncated p95-HER2, 500-fold selective forHER2 versus EGFR.
4.5
*For Research Use Only !
Change View
Size | Price | US Stock | Global Stock | In Stock |
1mg | łÇǶÊÊ | Inquiry | Inquiry | |
5mg | łÇò¶ÊÊ | Inquiry | Inquiry | |
10mg | łË˶ÊÊ | Inquiry | Inquiry | |
25mg | ł§§¶ÊÊ | Inquiry | Inquiry | |
100mg | łóď¶ÊÊ | Inquiry | Inquiry | |
250mg | łÇÍď¶ÊÊ | Inquiry | Inquiry | |
1g | ł§îď¶ÊÊ | Inquiry | Inquiry | |
5g | łÇ§óî¶ÊÊ | Inquiry | Inquiry |
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
łÇǶÊÊ
łÇò¶ÊÊ
łË˶ÊÊ
ł§§¶ÊÊ
łóď¶ÊÊ
łÇÍď¶ÊÊ
ł§îď¶ÊÊ
łÇ§óî¶ÊÊ
In Stock
- +
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 937263-43-9 |
Formula : | C26H24N8O2 |
M.W : | 480.52 |
SMILES Code : | CC1=CC(NC2=C3C=C(NC4=NC(C)(C)CO4)C=CC3=NC=N2)=CC=C1OC5=CC6=NC=NN6C=C5 |
InChI Key : | SDEAXTCZPQIFQM-UHFFFAOYSA-N |
Pubchem ID : | 51039094 |
GHS Pictogram: | ![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Target |
|
In Vitro:
Cell Line
| Concentration | Treated Time | Description | References |
MDCKII cells | 1 µM | 1 hour | To determine the passive transcellular permeability and interaction with ABCB1 and ABCG2 for Tucatinib | PMC9357092 |
HaCaT cells | 1 µM, 2.5 µM | 1 hour | To assess the efficacy of tucatinib in inhibiting ErbB2 phosphorylation, results showed that tucatinib effectively inhibited ErbB2 phosphorylation, particularly at Y877 and Y1221/1222 sites. | PMC10869470 |
BT474-Br | 0 to 200 nM | 4 days | To evaluate the effect of combined tucatinib and trastuzumab treatment on the proliferation of HER2+ breast cancer brain metastasis cells. The results showed that the combination therapy significantly inhibited tumor cell proliferation. | PMC8740706 |
AU565 | 0 to 200 nM | 4 days | To evaluate the effect of combined tucatinib and trastuzumab treatment on the proliferation of HER2+ breast cancer brain metastasis cells. The results showed that the combination therapy significantly inhibited tumor cell proliferation. | PMC8740706 |
BT474 | 10 nM | 72 hours | Tucatinib significantly reduced the metabolic activity of HER2-overexpressing BT474 cells and enhanced the effects of radiation therapy. | PMC11302197 |
ZR7530 | 10 nM | 72 hours | Tucatinib significantly reduced the metabolic activity of HER2-overexpressing ZR7530 cells and enhanced the effects of radiation therapy. | PMC11302197 |
HCC1954 | 1 µM | 72 hours | Tucatinib significantly reduced the metabolic activity of HER2-overexpressing HCC1954 cells and enhanced the effects of radiation therapy. | PMC11302197 |
SKBR3 cells | 100 nM | To evaluate the inhibitory effect of Tucatinib on HER2+ breast cancer cells, results showed that NF1-deficient cells exhibited resistance to Tucatinib. | PMC8602441 | |
HCC1954 cells | 2 µM | To evaluate the inhibitory effect of Tucatinib on HER2+ breast cancer cells, results showed that NF1-deficient cells exhibited resistance to Tucatinib. | PMC8602441 |
In Vivo:
Species
| Animal Model
| Administration | Dosage | Frequency | Description | References |
Mice | Orthotopic patient-derived xenografts of HER2+ breast cancer brain metastases | Oral | 75 mg/kg | Twice daily for several weeks | To evaluate the efficacy of combined treatment with tucatinib and abemaciclib in HER2+ breast cancer brain metastasis models, the results showed that the combined treatment significantly inhibited tumor growth and prolonged mouse survival. | PMC8933392 |
Mice | BT-474 xenograft model | Oral | 1 mg/kg | Daily for four weeks | To evaluate the therapeutic effect of MEK inhibitor on HER2+ breast cancer, results showed that NF1-deficient tumors exhibited a partial response to MEK inhibition. | PMC8602441 |
Nude mice | LS180-HER2 cell line-derived xenograft model | Intravenous injection | 10 mg/kg | Administered on day 1, 7, and 21 | Trastuzumab deruxtecan significantly delayed tumor progression and prolonged survival in the LS180-HER2 cell line-derived xenograft model. | PMC11018475 |
MMTV-Balb/c and FVB/N mice | HER2-positive breast cancer models | Oral | 25, 50, or 100 mg/kg | Once daily for 100 days or to ethical limits | Tucatinib significantly inhibited tumor growth in both models and demonstrated dose-dependent efficacy, and combination with PD-1 or PD-L1 inhibitors significantly improved survival in mice | PMC10323890 |
Nude mice | HER2+ breast cancer brain metastasis model | Oral | 20 mg/kg | Once daily for 21 consecutive days | To evaluate the effect of combined tucatinib and LM008-HER2Ab neural stem cell therapy on the survival of mice with HER2+ breast cancer brain metastasis. The results showed that the combination therapy significantly prolonged the survival of mice. | PMC8740706 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT05382364 | Metastatic HER2+ Advanced Brea... More >>st Cancer|Breast Neoplasms|Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)|Colorectal Cancer Less << | PHASE1 | ACTIVE_NOT_RECRUITING | 2025-12-29 | Harbin Medical University Canc... More >>er Hospital-oncology of department ( Site 0010), Harbin, Heilongjiang, 150000, China|Hunan Cancer Hospital-Digestion and Urology ( Site 0008), Changsha, Hunan, 421000, China|Jilin Cancer Hospital-oncology department ( Site 0007), Changchun, Jilin, 130012, China|Fudan University Shanghai Cancer Center-Oncology ( Site 0001), Shanghai, Shanghai, 200032, China|Tianjin Medical University Cancer Institute and Hospital-Gastric oncology ( Site 0005), Tianjin, Tianjin, 300060, China Less << |
NCT03914755 | Healthy | PHASE1 | COMPLETED | 2019-08-04 | PAREXEL International, Early P... More >>hase Clinical Unit - Los Angeles, Glendale, California, 91206, United States Less << |
NCT05892068 | Metastatic Breast Cancer | PHASE2 | RECRUITING | 2028-05-09 | Memorial Sloan Kettering Cance... More >>r Center (Limited Protocol Activities), Basking Ridge, New Jersey, 07920, United States|Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, 07748, United States|Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, 07645, United States|Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, 11725, United States|Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, 11553, United States Less << |
NCT04896320 | Breast Cancer Stage IV | PHASE1|PHASE2 | WITHDRAWN | 2023-06-19 | Providence Cancer Institute - ... More >>Clackamas Clinic, Clackamas, Oregon, 97015, United States|Providence Newberg Medical Center, Newberg, Oregon, 97132, United States|Portland Providence Medical Center, Portland, Oregon, 97213, United States|Providence St. Vincent Medical Center, Portland, Oregon, 97225, United States Less << |
NCT03424473 | - | NO_LONGER_AVAILABLE | - | - | |
NCT03722823 | Hepatic Impairment | PHASE1 | COMPLETED | 2019-05-07 | Orange County Research Center,... More >> Tustin, California, 92780, United States|Orlando Clinical Research Center, Orlando, Florida, 32809, United States|NOCCR Knoxville and Volunteer Research Group, Knoxville, Tennessee, 37920, United States|Texas Liver Institute, San Antonio, Texas, 78215, United States Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() | 1mg | 5mg | 10mg |
1 mM 5 mM 10 mM | 2.08mL 0.42mL 0.21mL | 10.41mL 2.08mL 1.04mL | 20.81mL 4.16mL 2.08mL |
Tags: Tucatinib | Irbinitinib | ARRY-380 | ONT-380 | ARRY380 | ARRY 380 | ARRY-380 | ONT380 | ONT 380 | ONT-380 | EGFR | Epidermal growth factor receptor | ErbB2 | HER2 | 937263-43-9
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL